导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -20.91% | 1003/1050 |
| 近一周 | -4.53% | 1038/1104 |
| 近一月 | -16.33% | 1101/1102 |
| 近一季 | -35.30% | 1089/1092 |
| 近半年 | -34.64% | 1060/1070 |
| 近一年 | -27.65% | 975/1018 |
| 近两年 | 4.93% | 867/926 |
| 近三年 | -13.86% | 749/834 |
| 成立以来 | 55.56% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
17.12% 14/1070 |
-3.03% 757/1101 |
- - |
- - |
| 2025 | 5.94% 869/1065 |
-0.59% 834/1014 |
-1.31% 800/1038 |
22.02% 539/1050 |
-11.51% 929/1065 |
| 2024 | 4.54% 441/1011 |
-3.78% 527/960 |
-6.49% 714/983 |
15.76% 187/991 |
0.37% 298/1011 |
| 2023 | -16.72% 589/952 |
2.45% 477/880 |
-5.39% 552/895 |
-11.52% 653/915 |
-2.90% 322/952 |
| 2022 | -25.13% 498/867 |
-22.51% 658/773 |
12.30% 181/806 |
-15.42% 590/845 |
1.73% 335/867 |
| 2021 | 33.08% 55/740 |
-8.08% 450/580 |
23.12% 114/659 |
15.44% 34/704 |
1.85% 361/740 |
| 2020 | 39.24% 300/554 |
-7.68% 349/419 |
23.56% 220/466 |
10.39% 244/517 |
10.58% 345/554 |
| 2019 | - - |
- - |
- - |
- - |
0.47% 384/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华宝绿色领先股票 VS. 东吴新产业精选股票A(580008) |